应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02591 银诺医药-B
休市中 11-07 15:59:31
30.000
-0.600
-1.96%
最高
30.780
最低
29.820
成交量
43.16万
今开
30.600
昨收
30.600
日振幅
3.14%
总市值
137.05亿
流通市值
126.09亿
总股本
4.57亿
成交额
1,305万
换手率
0.10%
流通股本
4.20亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
银诺医药-B11月07日主力净流出88.7万元 散户资金买入
市场透视 · 11-07 16:15
银诺医药-B11月07日主力净流出88.7万元 散户资金买入
银诺医药-B11月06日获主力加仓256.3万元
市场透视 · 11-06 16:15
银诺医药-B11月06日获主力加仓256.3万元
智通港股52周新高、新低统计|11月5日
智通财经 · 11-05 16:40
智通港股52周新高、新低统计|11月5日
银诺医药-B11月05日主力净流入141.4万元 散户资金抛售
市场透视 · 11-05 16:15
银诺医药-B11月05日主力净流入141.4万元 散户资金抛售
银诺医药-B及其子公司总计认购宁波银行105万元的结构性存款产品
美股速递 · 11-03
银诺医药-B及其子公司总计认购宁波银行105万元的结构性存款产品
银诺医药-B(02591)认购1.05亿元宁波银行结构性存款产品
智通财经 · 11-03
银诺医药-B(02591)认购1.05亿元宁波银行结构性存款产品
银诺医药-B10月28日主力净流入61.5万元 散户资金抛售
市场透视 · 10-28
银诺医药-B10月28日主力净流入61.5万元 散户资金抛售
银诺医药-B10月27日主力净流出62.4万元 散户资金买入
市场透视 · 10-27
银诺医药-B10月27日主力净流出62.4万元 散户资金买入
智通港股52周新高、新低统计|10月24日
智通财经 · 10-24
智通港股52周新高、新低统计|10月24日
从药品销售到患者服务:医药电商与药企合作迈进深水区
健识局 · 10-20
从药品销售到患者服务:医药电商与药企合作迈进深水区
生物科技股逆市有支撑 康宁杰瑞制药-B(09966)涨6.57% 机构指中国创新药正在“量变引起质变”
金吾财讯 · 10-17
生物科技股逆市有支撑 康宁杰瑞制药-B(09966)涨6.57% 机构指中国创新药正在“量变引起质变”
智通港股52周新高、新低统计|10月15日
智通财经 · 10-15
智通港股52周新高、新低统计|10月15日
今年产业规模有望破万亿,上海生物医药产业如何实现腾飞
澎湃新闻 · 10-15
今年产业规模有望破万亿,上海生物医药产业如何实现腾飞
银诺医药-B(02591):认购1.05亿元结构性存款产品
智通财经 · 10-14
银诺医药-B(02591):认购1.05亿元结构性存款产品
银诺医药-B10月08日主力净流出121.8万元 散户资金买入
市场透视 · 10-08
银诺医药-B10月08日主力净流出121.8万元 散户资金买入
银诺医药-B10月03日获主力加仓191.2万元
市场透视 · 10-03
银诺医药-B10月03日获主力加仓191.2万元
浦东生物医药企业竞逐“全球新”
新浪财经 · 09-30
浦东生物医药企业竞逐“全球新”
银诺医药-B(02591)已在中国完成核心产品(即依苏帕格鲁肽α)用于治疗肥胖和超重的III期临床试验的首例患者给药
智通财经 · 09-30
银诺医药-B(02591)已在中国完成核心产品(即依苏帕格鲁肽α)用于治疗肥胖和超重的III期临床试验的首例患者给药
银诺医药-B09月30日主力净流出57.6万元 散户资金买入
市场透视 · 09-30
银诺医药-B09月30日主力净流出57.6万元 散户资金买入
港股医药新锐布局AI
药智网 · 09-23
港股医药新锐布局AI
暂无数据
公司概况
公司名称:
银诺医药-B
所属市场:
SEHK
上市日期:
--
主营业务:
银诺医药成立于2014年,是一家科学驱动的生物制药公司,致力于为代谢性疾病患者提供创新的,可及且可负担的高质量药品。公司目前已拥有多项针对糖尿病、肥胖,代谢功能障碍相关适应症的研发管线,且所有管线均为自主研发,拥有全球专利,并布局全球研发和市场销售。 公司首个管线产品依苏帕格鲁肽α(曾用名:苏帕鲁肽,商品名:怡诺轻)于2025年1月份获中国国家药品监督管理局批准上市,成为我国首个国产原研的人源化长效GLP-1受体激动剂产品,将惠及更多的糖尿病患者。公司同时在开发依苏帕格鲁肽α减肥和代谢功能障碍相关的脂肪性肝炎适应症,以满足这些疾病领域巨大的未满足治疗需求。 银诺研发团队由国家特聘专家领衔,与具有多年创新药研发经验的科学家队伍组成,其创始人,董事长兼首席执行官,依苏帕格鲁肽α发明人王庆华博士是复旦大学特聘专家,十三五国家科技“重大新药创制”项目课题负责人。王庆华教授曾是多伦多大学的终身教授及世界领先的班廷百思特糖尿病研究所的常务委员。 银诺医药拥有先进的重组蛋白生物药技术平台可用于创新生物药的持续研发。
发行价格:
--
{"stockData":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"银诺医药-B","latestPrice":30,"timestamp":1762502371567,"preClose":30.6,"halted":0,"volume":431600,"delay":0,"floatShares":420285370,"shares":456819349,"eps":-0.45436536057209964,"marketStatus":"休市中","change":-0.6,"latestTime":"11-07 15:59:31","open":30.6,"high":30.78,"low":29.82,"amount":13049260,"amplitude":0.031373,"askPrice":30.12,"askSize":400,"bidPrice":30,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-0.5762654136600844,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1762738200000},"marketStatusCode":7,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":30.6,"openAndCloseTimeList":[[1762479000000,1762488000000],[1762491600000,1762502400000]],"volumeRatio":1.098331,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02591/tweets","defaultTab":"tweets","newsList":[{"id":"2581583580","title":"银诺医药-B11月07日主力净流出88.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2581583580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581583580?lang=zh_cn&edition=full","pubTime":"2025-11-07 16:15","pubTimestamp":1762503355,"startTime":"0","endTime":"0","summary":"11月07日, 银诺医药-B股价跌1.96%,报收30.00元,成交金额1304.9万元,换手率0.10%,振幅3.14%,量比1.10。银诺医药-B今日主力资金净流出88.7万元,上一交易日主力净流入256.3万元。该股近5个交易日下跌1.90%,主力资金累计净流入340.0万元;近20日主力资金累计净流入376.6万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107162148975a192b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107162148975a192b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2581790043","title":"银诺医药-B11月06日获主力加仓256.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581790043","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581790043?lang=zh_cn&edition=full","pubTime":"2025-11-06 16:15","pubTimestamp":1762416950,"startTime":"0","endTime":"0","summary":"11月06日, 银诺医药-B股价涨0.46%,报收30.60元,成交金额1326.6万元,换手率0.10%,振幅7.22%,量比1.10。银诺医药-B今日主力资金净流入256.3万元,上一交易日主力净流入141.4万元。该股近5个交易日上涨2.21%,主力资金累计净流入428.6万元;近20日主力资金累计净流入401.8万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106162050a6e55f71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106162050a6e55f71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2581812741","title":"智通港股52周新高、新低统计|11月5日","url":"https://stock-news.laohu8.com/highlight/detail?id=2581812741","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581812741?lang=zh_cn&edition=full","pubTime":"2025-11-05 16:40","pubTimestamp":1762332001,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止11月5日收盘,有48只股票创52周新高,其中乙德投资控股、LFG投资控股、天瑞汽车内饰创高率位于前3位,分别为40.63%、11.70%、11.11%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365527.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02520","00733","02670","02367","01286","01233","06603","00670","02270","01416","00830","01855","00341","01157","02591","01247","00599","00440","01745","00425","00659","06980","01238","06166","00894","01121","09922","00956","00813","01660","01707","02587","00844","02508","00191","01645","00066","02453","01795","02818","01481","00021","00204","00535","01341","01680","01133","01780","00848","01055"],"gpt_icon":0},{"id":"2581774363","title":"银诺医药-B11月05日主力净流入141.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2581774363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581774363?lang=zh_cn&edition=full","pubTime":"2025-11-05 16:15","pubTimestamp":1762330506,"startTime":"0","endTime":"0","summary":"11月05日, 银诺医药-B股价涨1.53%,报收30.46元,成交金额1300.5万元,换手率0.10%,振幅4.87%,量比1.24。银诺医药-B今日主力资金净流入141.4万元,上一交易日主力净流出0万元。该股近5个交易日上涨0.99%,主力资金累计净流入172.3万元;近20日主力资金累计净流入23.7万元,其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110516152197555302&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110516152197555302&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"1161763805","title":"银诺医药-B及其子公司总计认购宁波银行105万元的结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1161763805","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161763805?lang=zh_cn&edition=full","pubTime":"2025-11-03 19:45","pubTimestamp":1762170316,"startTime":"0","endTime":"0","summary":"银诺医药-B及其子公司总计认购宁波银行105万元的结构性存款产品","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2580926162","title":"银诺医药-B(02591)认购1.05亿元宁波银行结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2580926162","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580926162?lang=zh_cn&edition=full","pubTime":"2025-11-03 19:45","pubTimestamp":1762170311,"startTime":"0","endTime":"0","summary":"智通财经APP讯,银诺医药-B(02591)公布,于2025年11月3日,公司及银诺技术(公司一间直接全资附属公司)以代价合共人民币1.05亿元(即其总本金额)向宁波银行认购一款结构性存款产品(即宁波银行结构性存款产品)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2580892862.HKD","SGXZ81163826.USD","02591","LU2097828805.USD","SGXZ49509284.SGD","BK0201","LU1146622755.USD","LU2328871848.SGD","LU2097828631.EUR","BK1161","BK0188","LU1688375341.USD","LU1820825898.SGD","LU1720050803.USD","BK0197","BK0028","LU2097828474.EUR","002142","LU2097828714.EUR","LU1794554557.SGD","BK0187","BK0183","LU1969619763.USD","BK0278","LU2097828557.USD","LU2580892789.USD","LU0140636845.USD","LU1655091616.SGD"],"gpt_icon":0},{"id":"2579960303","title":"银诺医药-B10月28日主力净流入61.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2579960303","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579960303?lang=zh_cn&edition=full","pubTime":"2025-10-28 16:16","pubTimestamp":1761639362,"startTime":"0","endTime":"0","summary":"10月28日, 银诺医药-B股价涨0.53%,报收30.16元,成交金额696.4万元,换手率0.05%,振幅5.27%,量比0.69。银诺医药-B今日主力资金净流入61.5万元,上一交易日主力净流出62.4万元。该股近5个交易日下跌12.58%,主力资金累计净流出1.0万元;近20日主力资金累计净流入34.3万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028162326a6d25876&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028162326a6d25876&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2578621628","title":"银诺医药-B10月27日主力净流出62.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2578621628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578621628?lang=zh_cn&edition=full","pubTime":"2025-10-27 16:15","pubTimestamp":1761552928,"startTime":"0","endTime":"0","summary":"10月27日, 银诺医药-B股价跌5.36%,报收30.00元,成交金额1707.8万元,换手率0.13%,振幅11.55%,量比1.82。银诺医药-B今日主力资金净流出62.4万元,上一交易日主力净流出0万元。该股近5个交易日下跌14.29%,主力资金累计净流出62.4万元;近20日主力资金累计净流出27.2万元,其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027161703974452c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027161703974452c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2577525595","title":"智通港股52周新高、新低统计|10月24日","url":"https://stock-news.laohu8.com/highlight/detail?id=2577525595","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577525595?lang=zh_cn&edition=full","pubTime":"2025-10-24 16:40","pubTimestamp":1761295201,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止10月24日收盘,有60只股票创52周新高,其中康大食品、五矿地产、CMON创高率位于前3位,分别为121.62%、58.33%、43.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1359348.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01121","00875","01638","02477","02356","02358","00440","02495","02589","00465","00408","01792","02605","00393","02591","01645","01221","00834","01050","01176","09909","02600","01115","01757","01142","01745","02699","02289","02621","01959","00038","00924","01288","02223","00500","03798","01429","00482","00199","02313","00837","01339","00923","00230","01651","00381","02573","00023","01721","02011"],"gpt_icon":0},{"id":"2576852012","title":"从药品销售到患者服务:医药电商与药企合作迈进深水区","url":"https://stock-news.laohu8.com/highlight/detail?id=2576852012","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576852012?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:57","pubTimestamp":1760965074,"startTime":"0","endTime":"0","summary":"京东健康通过设立专区科普,患者教育、药师服务全方位提升用户体验,带动相关产品的销量大幅增长。让用户获得安全、可靠的药品,已属于整个医药电商行业的基本操作。恒安芙林药业的销售数据显示:使用京东用药提醒的患者,3个月复购率达传统渠道的2.1倍 。截至目前,京东健康在全国布局了20个医药冷链仓,覆盖400多个城市,搭建起中国唯一面向C端的标准医药冷链配送网络,能确保所有药品从出厂到用户手中的每一环节安全可控。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020210037a46a4408&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020210037a46a4408&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06618","BK1515","BK1571","BK1591","BK1615","BK1142","LU0051755006.USD","86618","BK1589","SGXZ62798434.SGD","SGXZ86797644.SGD","02591","BK1247","LU0456827905.SGD"],"gpt_icon":0},{"id":"2576709834","title":"生物科技股逆市有支撑 康宁杰瑞制药-B(09966)涨6.57% 机构指中国创新药正在“量变引起质变”","url":"https://stock-news.laohu8.com/highlight/detail?id=2576709834","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576709834?lang=zh_cn&edition=full","pubTime":"2025-10-17 10:17","pubTimestamp":1760667435,"startTime":"0","endTime":"0","summary":"华福证券指出,即将召开的欧洲肿瘤内科学会年会上公布的中国创新药临床数据,预计会成为市场主要关注点,也建议关注三季度业绩报告的披露和11月的国家医保谈判。该行表示,中国创新药正在“量变引起质变”,看好创新药5-10年的产业趋势,BD出海、持续数据催化和新产品销售放量将依次推动创新药崛起。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1967991","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","HK0000500386.USD","09966","159837","BK1161","02410","02509","02616","HK0000252152.HKD","LU2543165471.USD","06978","09606","02591","02197","BK1574","159992","02617"],"gpt_icon":0},{"id":"2575201765","title":"智通港股52周新高、新低统计|10月15日","url":"https://stock-news.laohu8.com/highlight/detail?id=2575201765","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575201765?lang=zh_cn&edition=full","pubTime":"2025-10-15 16:40","pubTimestamp":1760517601,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止10月15日收盘,有52只股票创52周新高,其中嘉宏教育、高阳科技、丰银禾控股创高率位于前3位,分别为27.72%、21.67%、21.44%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1355318.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06603","01044","01823","00089","00340","00733","01274","01597","02307","02497","00639","01459","00837","00684","01301","00132","01935","02025","02699","01660","01157","03808","02486","00182","00670","01115","01410","00924","00471","01851","03323","01097","00631","00257","02210","01808","00818","00314","01837","03737","01773","01872","02289","02680","00975","02688","00914","02591","02451","02543"],"gpt_icon":0},{"id":"2575270090","title":"今年产业规模有望破万亿,上海生物医药产业如何实现腾飞","url":"https://stock-news.laohu8.com/highlight/detail?id=2575270090","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575270090?lang=zh_cn&edition=full","pubTime":"2025-10-15 11:31","pubTimestamp":1760499073,"startTime":"0","endTime":"0","summary":"10月13日-17日,2025上海国际生物医药产业周持续进行中。展望万亿元新台阶,此次活动全方位展现了生物医药产业创新高地的应有之义。而在一周的会期之外,是上海常态化的对生物医药产业的极力托举。2025年上半年产业规模5005.66亿元,全年有望突破万亿。近年来,上海生物医药产业全速向前发展,获批创新药械数量更是衡量创新水平的“金标准”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101511344994c9fa05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101511344994c9fa05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","01877","BK1161"],"gpt_icon":0},{"id":"2575216055","title":"银诺医药-B(02591):认购1.05亿元结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2575216055","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575216055?lang=zh_cn&edition=full","pubTime":"2025-10-14 21:45","pubTimestamp":1760449541,"startTime":"0","endTime":"0","summary":"智通财经APP讯,银诺医药-B(02591)发布公告,于2025年10月14日,公司及银诺技术(公司一间直接全资附属公司)以代价合共人民币1.05亿元(即其总本金额)向宁波银行认购一项银行结构性存款产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1355032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2574397974","title":"银诺医药-B10月08日主力净流出121.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2574397974","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574397974?lang=zh_cn&edition=full","pubTime":"2025-10-08 16:15","pubTimestamp":1759911356,"startTime":"0","endTime":"0","summary":"10月08日, 银诺医药-B股价跌4.82%,报收39.50元,成交金额1224.4万元,换手率0.07%,振幅5.54%,量比0.65。银诺医药-B今日主力资金净流出121.8万元,上一交易日主力净流出0万元。该股近5个交易日下跌3.75%,主力资金累计净流入19.5万元;近20日主力资金累计净流出229.8万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008162054a456f026&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008162054a456f026&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2572502048","title":"银诺医药-B10月03日获主力加仓191.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572502048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572502048?lang=zh_cn&edition=full","pubTime":"2025-10-03 16:16","pubTimestamp":1759479362,"startTime":"0","endTime":"0","summary":"10月03日, 银诺医药-B股价涨1.91%,报收40.64元,成交金额2037.8万元,换手率0.12%,振幅8.27%,量比1.07。银诺医药-B今日主力资金净流入191.2万元,上一交易日主力净流入7.7万元。该股近5个交易日下跌2.73%,主力资金累计净流入182.9万元;近20日主力资金累计净流出3.9万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003162140971e34d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003162140971e34d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2571134119","title":"浦东生物医药企业竞逐“全球新”","url":"https://stock-news.laohu8.com/highlight/detail?id=2571134119","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571134119?lang=zh_cn&edition=full","pubTime":"2025-09-30 18:22","pubTimestamp":1759227774,"startTime":"0","endTime":"0","summary":"今年以来,浦东生物医药企业资本市场表现活跃:劲方医药、银诺医药已赴港上市,多家企业密集递交申请。自2018年君实生物成为张江药谷首家港股18A上市企业后,浦东药企赴港上市热潮涌动,产业正从“量变”迈向“质变”。出海方面,今年上半年浦东生物医药企业出海交易近30起,交易额占全国31%、全球14%。据悉,浦东将在2025上海国际生物医药产业周期间,围绕“源头创新 链聚全球”推出更多服务与政策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930183301954e19e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930183301954e19e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1161","BK1515","BK1574","09939","02595","02591"],"gpt_icon":1},{"id":"2571103383","title":"银诺医药-B(02591)已在中国完成核心产品(即依苏帕格鲁肽α)用于治疗肥胖和超重的III期临床试验的首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2571103383","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571103383?lang=zh_cn&edition=full","pubTime":"2025-09-30 17:05","pubTimestamp":1759223106,"startTime":"0","endTime":"0","summary":"智通财经APP讯,银诺医药-B(02591)发布公告,于2025年9月30日,公司已在中国完成核心产品(即依苏帕格鲁肽α)用于治疗肥胖和超重的III期临床试验的首例患者给药。公司计划就该临床试验招募大约800位参与者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1351279.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","02591","BK1161","BK4134"],"gpt_icon":0},{"id":"2572532227","title":"银诺医药-B09月30日主力净流出57.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2572532227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572532227?lang=zh_cn&edition=full","pubTime":"2025-09-30 16:15","pubTimestamp":1759220131,"startTime":"0","endTime":"0","summary":"09月30日, 银诺医药-B股价跌4.19%,报收39.32元,成交金额1656.3万元,换手率0.10%,振幅4.97%,量比0.90。银诺医药-B今日主力资金净流出57.6万元,上一交易日主力净流入41.7万元。该股近5个交易日下跌5.48%,主力资金累计净流出16.0万元;近20日主力资金累计净流出187.0万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930161741a6a7fafe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930161741a6a7fafe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2569750924","title":"港股医药新锐布局AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2569750924","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569750924?lang=zh_cn&edition=full","pubTime":"2025-09-23 10:03","pubTimestamp":1758592982,"startTime":"0","endTime":"0","summary":"9月22日,银诺医药宣布与迈富时达成战略合作。银诺医药也因此成为全球第三家、亚洲首家在商业化阶段拥有自主知识产权的企业。银诺医药此次跨界合作,通过AI赋能,有望在医患服务、市场洞察等方面实现“弯道超车”,增强市场竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923100538a43d86c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923100538a43d86c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1618","02556","BK1518","BK1161","02591","BK1109"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.2405},{"period":"3month","weight":0.606},{"period":"ytd","weight":0.606}],"compareEarnings":[{"period":"1week","weight":0.0129},{"period":"1month","weight":-0.0219},{"period":"3month","weight":0.0556},{"period":"6month","weight":0.1475},{"period":"1year","weight":0.2524},{"period":"ytd","weight":0.3082}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"银诺医药成立于2014年,是一家科学驱动的生物制药公司,致力于为代谢性疾病患者提供创新的,可及且可负担的高质量药品。公司目前已拥有多项针对糖尿病、肥胖,代谢功能障碍相关适应症的研发管线,且所有管线均为自主研发,拥有全球专利,并布局全球研发和市场销售。\n公司首个管线产品依苏帕格鲁肽α(曾用名:苏帕鲁肽,商品名:怡诺轻)于2025年1月份获中国国家药品监督管理局批准上市,成为我国首个国产原研的人源化长效GLP-1受体激动剂产品,将惠及更多的糖尿病患者。公司同时在开发依苏帕格鲁肽α减肥和代谢功能障碍相关的脂肪性肝炎适应症,以满足这些疾病领域巨大的未满足治疗需求。\n银诺研发团队由国家特聘专家领衔,与具有多年创新药研发经验的科学家队伍组成,其创始人,董事长兼首席执行官,依苏帕格鲁肽α发明人王庆华博士是复旦大学特聘专家,十三五国家科技“重大新药创制”项目课题负责人。王庆华教授曾是多伦多大学的终身教授及世界领先的班廷百思特糖尿病研究所的常务委员。\n银诺医药拥有先进的重组蛋白生物药技术平台可用于创新生物药的持续研发。","exchange":"SEHK","name":"银诺医药-B","nameEN":"INNOGEN-B"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"银诺医药-B(02591)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供银诺医药-B(02591)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"银诺医药-B,02591,银诺医药-B股票,银诺医药-B股票老虎,银诺医药-B股票老虎国际,银诺医药-B行情,银诺医药-B股票行情,银诺医药-B股价,银诺医药-B股市,银诺医药-B股票价格,银诺医药-B股票交易,银诺医药-B股票购买,银诺医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"银诺医药-B(02591)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供银诺医药-B(02591)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}